152 related articles for article (PubMed ID: 21042216)
41. Apolipoprotein A-I mimetics and high-density lipoprotein function.
Gordon SM; Davidson WS
Curr Opin Endocrinol Diabetes Obes; 2012 Apr; 19(2):109-14. PubMed ID: 22278086
[TBL] [Abstract][Full Text] [Related]
42. Peroxisome proliferator-activated receptors--from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease.
Bouhlel MA; Staels B; Chinetti-Gbaguidi G
J Intern Med; 2008 Jan; 263(1):28-42. PubMed ID: 18042221
[TBL] [Abstract][Full Text] [Related]
43. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
44. Vascular function and cardiovascular risk factors in women with severe flushing.
Sassarini J; Fox H; Ferrell W; Sattar N; Lumsden MA
Clin Endocrinol (Oxf); 2011 Jan; 74(1):97-103. PubMed ID: 21050255
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological therapies for raising HDL cholesterol beyond synthetic small molecules.
Garcia RA
Curr Opin Investig Drugs; 2008 Mar; 9(3):274-80. PubMed ID: 18311663
[TBL] [Abstract][Full Text] [Related]
46. Glitazones in the treatment of cardiovascular risk factors.
Bouhlel MA; Chinetti-Gbaguidi G; Staels B
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():7-13. PubMed ID: 18001313
[TBL] [Abstract][Full Text] [Related]
47. Anti-inflammatory drugs and atherosclerosis.
Moubayed SP; Heinonen TM; Tardif JC
Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
[TBL] [Abstract][Full Text] [Related]
48. [Reverse cholesterol transport processes and their role in artherosclerosis regression].
Chachaj A; Drozdz K; Szuba A
Postepy Biochem; 2008; 54(3):301-7. PubMed ID: 19112829
[TBL] [Abstract][Full Text] [Related]
49. HDL Mimetic Peptides.
Chen J; Liu J; Yu B
Adv Exp Med Biol; 2022; 1377():141-151. PubMed ID: 35575927
[TBL] [Abstract][Full Text] [Related]
50. Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia.
Wolkowicz P; White CR; Anantharamaiah GM
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33922449
[TBL] [Abstract][Full Text] [Related]
51. Peptides as Therapeutic Agents for Atherosclerosis.
White CR; Palgunachari M; Wolkowicz P; Anantharamaiah GM
Methods Mol Biol; 2022; 2419():89-110. PubMed ID: 35237960
[TBL] [Abstract][Full Text] [Related]
52. New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease.
Barter PJ; Puranik R; Rye KA
Curr Cardiol Rep; 2007 Nov; 9(6):493-8. PubMed ID: 17999875
[TBL] [Abstract][Full Text] [Related]
53. The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis.
Navab M; Anantharamaiah GM; Fogelman AM
Trends Cardiovasc Med; 2008 Feb; 18(2):61-6. PubMed ID: 18308197
[TBL] [Abstract][Full Text] [Related]
54. The modern art of atherosclerosis: a picture of colorful plants, cholesterol, and inflammation.
Frolov A; Hui DY
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):450-2. PubMed ID: 17301323
[No Abstract] [Full Text] [Related]
55. From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?
Ridker PM
Cardiovasc Res; 2021 Sep; 117(11):e138-e140. PubMed ID: 34352102
[No Abstract] [Full Text] [Related]
56. Apolipoprotein A-I mimetics.
Reddy ST; Navab M; Anantharamaiah GM; Fogelman AM
Curr Opin Lipidol; 2014 Aug; 25(4):304-8. PubMed ID: 24977978
[TBL] [Abstract][Full Text] [Related]
57. Novel insights into anti-inflammatory actions of HDL.
van Wijk DF; Stroes ES; Dallinga-Thie GM
Atherosclerosis; 2010 Oct; 212(2):388-9. PubMed ID: 20650459
[No Abstract] [Full Text] [Related]
58. New methodology and approaches to intracellular lipid transport in atherosclerosis and cardiovascular disease.
Roufogalis BD; Grewal T
Curr Pharm Biotechnol; 2012 Feb; 13(2):276-7. PubMed ID: 21470126
[No Abstract] [Full Text] [Related]
59. Apolipoprotein-mimetic Peptides: Current and Future Prospectives.
Nankar SA; Ahmed S; Sharma SS; Pande AH
Curr Protein Pept Sci; 2022; 23(11):757-772. PubMed ID: 36200201
[TBL] [Abstract][Full Text] [Related]
60. American College of Cardiology--58th annual scientific session.
Wong NC
IDrugs; 2009 May; 12(5):291-3. PubMed ID: 19431092
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
